Skip to main content
. 2018 Jun 14;10(1):24–36. doi: 10.1007/s13340-018-0360-4

Fig. 5.

Fig. 5

Meta-analysis results for the association of cumulative exposure duration (vs. never use) random to pioglitazone and bladder cancer. Studies included in the meta-analysis are shown with the adjusted risk estimates, 95% CI, and the relative weight in the meta-analysis. The meta-analysis results were derived using a random-effects model